Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women

Inclusion Criteria: * Primary breast cancer after surgical treatment, pathologically diagnosed malignant breast epithelial tumors (breast cancer), immunohistochemistry showed pathological type of estrogen receptor (ER) and / or progesterone receptor (PR) positive. * Participants should be currently receiving endocrine therapy with oral administration of SERMS(selective estrogen receptor modulators) only. * Participants should be suffered from perimenopausal symptoms,which is the sudden onset of facial skin flushing, sweating, began from chest and neck,often lasts a few seconds to several minutes and then subsided after center body temperature drops, the associated symptoms of heart palpitations, anxiety, impatience and even a sense of panic, and even wake up at night. The interval between the two attacks is more than 10 minutes. * Hot flashes occurs during endocrine therapy of breast cancer * KPS score \>60 score \>2 and ECOG * Hot flashes (greater than or equal to 3 times the number of hot flashes per day) * Symptoms persist for more than 2 weeks Exclusion Criteria: * Participants who have uncontrolled diabetes, hyperthyroidism and hypertension and in patients with pheochromocytoma * Abnormal blood routine, liver and kidney damage (the index is greater than 1.2 times the upper limit of normal value) * Pregnant or lactating women, persons with mental disorders * Participants with other cancers * Participants are participating in other clinical trials * Current chemotherapy treatment period has not yet completed * Taking corticosteroids or sex hormone treatment.